1. Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases

   • Thomas J. Feuerstein
   • Miriam Kammerer
   • Andreas Moser

   REVIEW 02 May 2011 Pages: 1 - 20

   

2. MEK inhibition suppresses the development of lung fibrosis in the bleomycin model

   • Maria Galuppo
   • Emanuela Esposito
   • Salvatore Cuzzocrea

   ORIGINAL ARTICLE 02 May 2011 Pages: 21 - 37

   

3. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats

   • Johan P. Rung
   • Emilia Rung
   • Maria L. Carlsson

   ORIGINAL ARTICLE 02 May 2011 Pages: 39 - 45

   

4. Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes

   • M. Kammerer
   • M. P. Rassner
   • T. J. Feuerstein

   ORIGINAL ARTICLE 02 May 2011 Pages: 47 - 57

   

5. Idebenone inhibition of glutamate release from rat cerebral cortex nerve endings by suppression of voltage-dependent calcium influx and protein kinase A

   • Yi Chang
   • Yu-Wan Lin
   • Su-Jane Wang

   ORIGINAL ARTICLE 04 May 2011 Pages: 59 - 70

   

6. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor

   • Jillian G. Baker
   • Richard G. W. Proudman
   • Christopher G. Tate

   ORIGINAL ARTICLE Open access 06 May 2011 Pages: 71 - 91

   

7. Wound healing activity of carbon monoxide liberated from CO-releasing molecule (CO-RM)

   • Azad Ahmad Ahanger
   • Shahid Prawez
   • Dinesh Kumar

   ORIGINAL ARTICLE 17 May 2011 Pages: 93 - 102

   

8. Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice

   • Keita Shibata
   • Terumasa Hashimoto
   • Kazuo Honda

   SHORT COMMUNICATION 02 May 2011 Pages: 103 - 108